29 matches for your search in the start-up spotlight
rss
Another milestone reached: researchers work together with Swiss biotech start-up to further develop the vaccine
29-Feb-2024
Rocketvax AG, together with the German Research Foundation (DFG), has financially supported a study carried out as part of a joint project of the Swiss National Science Foundation (SNSF, National Research Program “Covid-19,” NRP 78) and the German Research Foundation (DFG) “Recoding the ...
New vaccine technology could protect from future Coronaviruses and variants
05-Oct-2023
Studies of a ‘future-proof’ vaccine antigen candidate have shown that just one antigen can be modified to provide a broadly protective immune response in animals, suggesting that a single vaccine with combinations of these novel antigens could protect against an even greater range of current and ...
University of Basel and biotech start-up RocketVax present a vaccine concept that could lead to a new generation of vaccines
25-May-2023
Researchers at the University of Basel have developed a new approach for a vaccine against COVID-19. This vaccine is based on a modified coronavirus that can enter body cells and trigger an effective immune response but cannot multiply in the body. In animal studies, the vaccine effectively ...
(Ex-)employees found start-up "Panadea Diagnostics”
03-Apr-2023
Scientists with entrepreneurial spirit: Researchers at the Bernhard Nocht Institute for Tropical Medicine (BNITM) have developed and patented a special technology for antibody detection, which will be marketed from April by a company founded specifically for this purpose. The board of the BNITM ...
Spear Bio is working towards commercializing its first assay, which accurately assesses levels of SARS-CoV-2-neutralizing antibodies in dried-blood spot samples
13-Sep-2022
The Wyss Institute for Biologically Inspired Engineering at Harvard University and Spear Bio, Inc. announced that the Institute’s DNA nanotechnology-driven ultrasensitive SPEAR protein-detection technology has been licensed to the newly formed Boston-based startup. Spear Bio has signed a ...
Biotech-Start-up G.ST Antivirals starts first clinical trial
16-May-2022
Less than three years after its foundation, the start-up G.ST Antivirals reaches a major milestone in the development of its lead asset and begins clinical phase I at the Vienna General Hospital. G.ST Antivirals is testing a nasal spray, which was developed specifically for use against colds and ...
A California-based start-up is currently raising funds for human trials, drug development, formulation and mass production
31-Mar-2022
A newly discovered small molecule could be sprayed into people’s noses to prevent COVID-19 illness prior to exposure and provide early treatment if administered soon after infection, according to a study in mice led by Cornell University researchers. The study, published in Nature, employed ...
Startup develop an RNA-based drug
18-Jan-2022
rnatics, a startup at the Technical University of Munich (TUM), has created an RNA-based drug to prevent lung damage from infections as seen in serious Covid-19 cases. The Federal Ministry of Education and Research (BMBF) is providing 7 million euros in funding to support the development of the ...
13-Jan-2022
Pantherna Therapeutics announces the successful completion of a follow-on financing round totaling EUR 4.0 Mio. led by existing investors Riesner Verwaltungs GmbH and High-Tech Gründerfonds. The proceeds of this round will be used to accelerate preclinical development activities for its lead ...
Biotechnology Breakthrough by start-up DreamTec
06-Jan-2022
Vaccines have been a trending topic ever since the coronavirus outbreak two years ago. DreamTec Research Limited has its major breakthrough in developing a COVID-19 oral vaccine. In its recently published peer-reviewed paper in an international medical journal Vaccines,which demonstrates ...
